Clinical Trial: A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836037) titled 'A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)' on Feb. 18.

Brief Summary: The goal of this study is to learn about the safety and whether people tolerate a study medicine called efinopegdutide. The study will also measure what happens to efinopegdutide in a healthy person's body over time.

Study Start Date: Sept. 05, 2022

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Efinopegdutide

Subcutaneous inejction

DRUG: Placebo

placebo matching efinopegdutide

Recruitment Status: COMPLETED

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by HT Syndication....